Dementia: New projections and time for an updated response

Australian and New Zealand Journal of Psychiatry

Volumn 39, Issue 11-12, 2005, Pages 955-958

  Brodaty, Henry ^a   Sachdev, Perminder ^a   Anderson, Tracy M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ESTROGEN; FOLIC ACID; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALZHEIMER DISEASE; AUSTRALIA; CLINICAL TRIAL; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; EARLY DIAGNOSIS; ECONOMIC ASPECT; EDITORIAL; FAMILY SIZE; HEALTH CARE COST; HEALTH CARE POLICY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INCIDENCE; META ANALYSIS; MULTIINFARCT DEMENTIA; PATHOGENESIS; PREDICTION; PREVALENCE; PRIMARY PREVENTION; QUALITY OF LIFE; RELIABILITY; RISK FACTOR; SMOKING; SOCIAL ASPECT; STROKE; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

AUSTRALIA; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COMORBIDITY; DEMENTIA; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; PREVALENCE;

EID: 33745210334     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2005.01712.x     Document Type: Editorial

References (22)

1. Jorm AF, Korten AA. Method for calculating projected increases in the number of dementia sufferers. Australian and New Zealand Journal of Psychiatry 1988; 22: 183-89.
2. Henderson AS, Jorm AF. The problem of dementia in Australia. Canberra: Australian Government Printing Service, 1986.
3. Access Economics. The dementia epidemic: Economic impact and positive solutions for Australia, 2003 report. Available from URL: http://www.alzheimers.org.au
4. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of differential diagnostic criteria on the prevalence of dementia. New England Journal of Medicine 1997; 337: 1667-1674.
5. Wetterling T, Kanitz R-D, Borgis K-J. Comparison of different criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996; 27: 30-36.
6. Petersen RC. Mild cognitive impairment: Aging to Alzheimer's disease. New York: Oxford University Press, 2003.
7. Hachinski VC. Preventable senility: A call for action against the vascular dementias. Lancet 1992; 340: 645-647.
8. Gorelick PB. Can we save the brain from the ravages of midlife cardiovascular risk factors?Neurology 1999; 52: 1114-1115.
9. Forette F, Seux M-L, Staessen JA et al. Prevention of dementia in randomized double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-1351.
10. Mayeaux R. Epidemiology of neurodegeneration. Annual Review of Neuroscience 2003; 26: 81-104.
11. Marx J. Preventing Alzheimer's: A lifelong commitment. Science 2005; 309: 864-866.
12. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health 1998; 88: 1337-1342.
13. Morris JC. Dementia update 2005. Alzheimer Disease and Associated Disorders 2005; 19: 100-117.
14. Toole JF, Malinow R, Chambless L et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. Journal of the American Medical Association 2004; 291: 565-575.
15. Shumaker SA, Legault C, Rapp SR et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association 2003; 289: 2651-2662.
16. Morris MC, Evans DA, Bienias JL et al. Dietary folate and vitamin B12 intake and cognitive decline in community-dwelling older persons. Archives of Neurology 2005; 62: 641-645.
17. Nitsch RM. Immunotherapy of Alzheimer disease. Alzheimer Disease and Associated Disorder 2004; 18: 185-189.
18. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. AIWH Cat. No. PHE 17. Canberra: AIWH, 1999.
19. Stouthard MEA, Essink-Bot ML, Bonsel GJ et al. Disability weights for diseases in the Netherlands. Rotterdam: Department of Public Health, 1997.
20. Richardson J, Day N, Peacock S, Iezzi A. Measurement of the quality of life for economic evaluation and the assessment of quality of life (AQoL) mark 2 instrument. The Australian Economic Review 2004; 37: 62-88.
21. Australian Government 2005 Federal Budget: Ministry for Ageing Media Release JB120/05, 7 August 2005. Available from URL: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/ health-mediarel-yr2005-jb0bis120.htm
22. National Framework for Action on Dementia, 2005 consultation paper. Available from URL: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ ageing-dementia-nfad.htm